Sarpogrelate Hydrochloride Extended-Release Tablet
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Aprogen Biologics, Co., Ltd.
MFDS item code 201903500 · Approved 2019.05.28
This product's status changed to Expired on 2024.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of ischemic symptoms (ulcer, pain) in chronic arterial occlusive disease
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensation due to chronic arterial occlusive disease. It alleviates blood circulation disorders caused by various reasons such as Buerger's disease, obstructive arteriosclerosis, and diabetic peripheral vascular disease, thus reducing symptoms. It helps improve the quality of life by alleviating the uncomfortable symptoms that patients experience.
Administer 300 mg of Sarpogrelate Hydrochloride extended-release tablet orally once daily after meals. This medication should be taken as a whole without chewing or breaking.
This medication should not be used in patients with bleeding as it may increase the risk of bleeding. It is safe not to administer to pregnant women or those who may become pregnant, as it could affect the fetus. Patients who are menstruating or have a tendency to bleed, as well as those taking anticoagulants or platelet aggregation inhibitors, should use this medication cautiously due to the increased risk of bleeding. Patients with severely impaired kidney function or the elderly may also be affected by drug excretion and reactions, so caution is needed. This medication may cause various side effects such as urticaria, dyspepsia, headache, and cough, and serious adverse reactions such as bleeding, liver function abnormalities, and blood disorders may also occur. Regular blood tests during medication use are important to detect adverse reactions early. Caution is especially necessary when taken in combination with anticoagulants or platelet aggregation inhibitors due to the increased risk of bleeding. Pregnant or breastfeeding women are advised not to take this medication, and if unavoidable, must consult a health care professional. The safety of this medication has not been established in children, so it is advisable not to use it. Store the medication out of reach of children and take care not to transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air or moisture and is best kept at a temperature between 1°C and 30°C. Maintaining the appropriate temperature ensures the drug's effectiveness.
White oblong film-coated tablet
100 tablets per bottle, 30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Aprogen Biologics, Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.